Try Alerts Free   |   Login

Titan Pharmaceuticals Financials and Smart Investor 13F Alerts

TTNP Sector: Health Care, Biological Products (No Diagnostic Substances)

Data imported from SEC filings and provided as-is without any warranty. Check Titan Pharmaceuticals Inc filings before making any investment decision.

TTNP stock chart compared to Revenue:
Get email alerts for new filings: We will never share your email address. By submitting your email, you agree to our Terms of Service and Privacy Policy.

TTNP Income Statement

Revenue, Net:1325000
Cost of Goods and Services Sold:228000
Selling, General and Administrative Expense:3474000
Research and Development Expense:2007000
Total Operating Expenses:5709000
Operating Income:-4384000
Net Income (Loss) Attributable to Parent:-4641000
Earnings Per Share, Diluted:-0.05
Earnings Per Share, Basic:-0.05
Weighted Average Number of Shares Outstanding, Basic:97223180
Weighted Average Number of Shares Outstanding, Diluted:94930000

TTNP Cash Flow

Depreciation, Depletion and Amortization:66000
Change in Accounts Receiveable:-490000
Net Cash from Operations:-3983000
Net Cash from Financing Activities:1500000
Payments to Acquire Property, Plant, and Equipment:57000
Net Cash from Investing Activities:-57000
Net Change in Cash and Cash Equivalents:null

TTNP Balance Sheet

Cash and Cash Equivalents:5498000
Accounts Receivable, Net:1061000
Inventories:969000
Total Current Assets:8690000
Property, Plant and Equipment, Net:799000
Total Assets:9762000
Accounts Payable:1528000
Current Portion of Long-Term Debt:1624000
Total Short-Term Liabilities:4857000
Long Term Debt, Non-Current Portion:3345000
Total Liabilities:8202000